Clinical and Sialographic Imaging Features of 131I Radiation-induced Submandibular Gland Sialadenitis.

[1]  Alessandra Bianchi,et al.  Juvenile recurrent parotitis: Diagnostic and therapeutic effectiveness of sialography. Retrospective study on 110 children. , 2019, International journal of pediatric otorhinolaryngology.

[2]  Xin Yue Wang,et al.  Phenylephrine Alleviates 131I Radiation Damage in Submandibular Gland Through Maintaining Mitochondrial Homeostasis. , 2019, International journal of radiation oncology, biology, physics.

[3]  P. Wang,et al.  Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial , 2017, Nuclear medicine communications.

[4]  X. Long,et al.  Sialoendoscopy combined with an internal stent and postoperative massage as a comprehensive treatment of delayed I131-induced parotitis. , 2017, The British journal of oral & maxillofacial surgery.

[5]  P. Wang,et al.  Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer , 2017, Medicine.

[6]  S. Mukherji,et al.  Imaging of sialadenitis , 2017, The neuroradiology journal.

[7]  D. W. Kim.  Computed tomography features of the major salivary glands after radioactive iodine ablation in patients with papillary thyroid carcinoma , 2017, La radiologia medica.

[8]  K. Coombes,et al.  Risk Factors of 131I-Induced Salivary Gland Damage in Thyroid Cancer Patients. , 2016, The Journal of clinical endocrinology and metabolism.

[9]  Daniel G Rey Caro,et al.  Sialadenitis after radioiodine therapy. Analysis of factors that influence the response to medical treatment. , 2015, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

[10]  Ali Bijani,et al.  Vitamin E protects salivary glands dysfunction induced by ionizing radiation in rats. , 2015, Archives of oral biology.

[11]  Young-Mo Kim,et al.  Usefulness of Magnetic Resonance Sialography for the Evaluation of Radioactive Iodine-Induced Sialadenitis , 2015, Annals of Surgical Oncology.

[12]  H. N. Lee,et al.  Salivary gland dysfunction after radioactive iodine (I-131) therapy in patients following total thyroidectomy: emphasis on radioactive iodine therapy dose. , 2015, Clinical imaging.

[13]  R. Nagy,et al.  Modulation of sodium/iodide symporter expression in the salivary gland. , 2013, Thyroid : official journal of the American Thyroid Association.

[14]  Su Jin Lee,et al.  Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer , 2013, Annals of Nuclear Medicine.

[15]  A. Okizaki,et al.  Assessment of Salivary Gland Dysfunction after Radioiodine Therapy for Thyroid Carcinoma Using Non-Contrast-Enhanced CT: The Significance of Changes in Volume and Attenuation of the Glands , 2012, American Journal of Neuroradiology.

[16]  L. Orloff,et al.  Therapeutic sialendoscopy for the management of radioiodine sialadenitis. , 2012, Archives of otolaryngology--head & neck surgery.

[17]  A. Bockisch,et al.  The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  B. Liu,et al.  Influence of Vitamin C on Salivary Absorbed Dose of 131I in Thyroid Cancer Patients: A Prospective, Randomized, Single-Blind, Controlled Trial , 2010, Journal of Nuclear Medicine.

[19]  Soon-Chul Choi,et al.  The relationship between sialographic images and clinical symptoms of inflammatory parotid gland diseases. , 2009, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[20]  W. Brenner,et al.  Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer , 1999, Strahlentherapie und Onkologie.

[21]  C. Harmer,et al.  Salivary gland toxicity after radioiodine therapy for thyroid cancer. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[22]  A. Khan,et al.  Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy , 2006, Nuclear medicine communications.

[23]  S. Chow.  Side Effects of High-dose Radioactive Iodine for Ablation or Treatment of Differentiated Thyroid Carcinoma , 2005 .

[24]  K. Nakajima,et al.  Multifactorial analysis on the short-term side effects occurring within 96 hour after radioiodine-131 therapy for differentiated thyroid carcinoma , 2004, Annals of nuclear medicine.

[25]  S. Mandel,et al.  Radioactive iodine and the salivary glands. , 2003, Thyroid : official journal of the American Thyroid Association.

[26]  M. Tuncel,et al.  Scintigraphic Evaluation of Salivary Gland Dysfunction in Patients with Thyroid Cancer After Radioiodine Treatment , 2002, Clinical nuclear medicine.

[27]  R. Nagler.  The enigmatic mechanism of irradiation-induced damage to the major salivary glands. , 2002, Oral diseases.

[28]  R. Solans,et al.  Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  M. Ringel,et al.  The Role of Radioactive Iodine in Salivary Gland Dysfunction , 2000, Ear, nose, & throat journal.

[30]  J. Bidart,et al.  Immunohistochemical analysis of Na+/I- symporter distribution in human extra-thyroidal tissues. , 1999, European journal of endocrinology.

[31]  A. Fischer,et al.  An immunohistochemical study of Na+/I- symporter in human thyroid tissues and salivary gland tissues. , 1998, Endocrinology.

[32]  C. Kirsch,et al.  Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  R. Cavalieri.  Iodine metabolism and thyroid physiology: current concepts. , 1997, Thyroid : official journal of the American Thyroid Association.

[34]  S. J. Wang,et al.  Short-term hazards of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients. , 1996, Clinical nuclear medicine.

[35]  B. Malpani,et al.  Quantification of salivary gland function in thyroid cancer patients treated with radioiodine. , 1996, International journal of radiation oncology, biology, physics.

[36]  D. van Nostrand,et al.  Side effects of "rational dose" iodine-131 therapy for metastatic well-differentiated thyroid carcinoma. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  J. Mallard,et al.  Radiation sialitis following radioiodine therapy. , 1957, The British journal of radiology.